C. Degott

S. Chevret, F. Carnot, C. Degott, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Influence of Hepatitis G Virus Infection on the Severity of Liver Disease and Response to Interferon- in Patients with Chronic Hepatitis C

P. Marcellin, C. Degott, A. Aupérin, 1997, Annals of Internal Medicine.

Prognostic influence of clinicopathologic features, DNA‐ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinoma in france

P. Laurent-Puig, C. Degott, J. Belghiti, 1997, International journal of cancer.

CD4+/CD8+ ratio of liver‐derived lymphocytes is related to viraemia and not to hepatitis C virus genotypes in chronic hepatitis C

P. Marcellin, C. Degott, J. Mosnier, 1995, Clinical and experimental immunology.

Etiology of chronic hepatitis in France: predominant role of hepatitis C virus.

P. Marcellin, C. Degott, B. Pham, 1994, Journal of hepatology.

Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C.

P. Marcellin, C. Degott, J. Scoazec, 1994, Gastroenterology.

The intraportal lymphoid nodule and its environment in chronic active hepatitis C: An immunohistochemical study

P. Marcellin, C. Degott, J. Mosnier, 1993, Hepatology.

Drug‐induced prolonged cholestasis in adults: A histological semiquantitative study demonstrating progressive ductopenia

C. Degott, G. Feldmann, J. Benhamou, 1992, Hepatology.

Recombinant human α‐interferon in patients with chronic non‐A, non‐B hepatitis: A multicenter randomized controlled trial from France

P. Couzigou, P. Marcellin, C. Degott, 1991 .

Randomized controlled trial of adenine arabinoside 5′‐monophosphate in chronic active hepatitis B: Comparison of the efficacy in heterosexual and homosexual patients

P. Marcellin, D. Ouzan, C. Degott, 1989, Hepatology.

Successful endoscopic obturation of gastric varices with butyl cyanoacrylate

D. Valla, C. Degott, J. Mosnier, 1989, Hepatology.

Arterial and portal circulation and parenchymal changes in Budd‐Chiari syndrome: A study in 17 explanted livers

V. Vilgrain, D. Valla, C. Degott, 2003, Hepatology.

Histologic scoring of liver biopsy in focal nodular hyperplasia with atypical presentation

V. Vilgrain, D. Valla, C. Degott, 2002, Hepatology.

Liver adenomatosis. An entity distinct from liver adenoma?

C. Degott, H. Bismuth, J. Benhamou, 1985, Gastroenterology.

Invasion of the lumen of the bile ducts by hepatocellular carcinoma.

C. Degott, J. Benhamou, G. Carella, 2008, Liver.

Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.

C. Degott, J. Belghiti, B. Terris, 2001, American journal of clinical pathology.

Additive effects of inducers and fasting on acetaminophen hepatotoxicity.

D. Pessayre, C. Degott, J. Benhamou, 1980, Biochemical pharmacology.

Hepatotoxicity of germander in mice.

D. Pessayre, C. Degott, P. Dansette, 1994, Gastroenterology.

Methoxsalen decreases the metabolic activation and prevents the hepatotoxicity and nephrotoxicity of chloroform in mice.

G. Labbe, D. Pessayre, C. Degott, 1987, Toxicology and applied pharmacology.

The drug methoxsalen, a suicide substrate for cytochrome P-450, decreases the metabolic activation, and prevents the hepatotoxicity, of carbon tetrachloride in mice.

G. Labbe, D. Pessayre, C. Degott, 1987, Biochemical pharmacology.

Regulation of renal cytochrome P-450. Effects of two-thirds hepatectomy, cholestasis, biliary cirrhosis and post-necrotic cirrhosis on hepatic and renal microsomal enzymes.

D. Pessayre, C. Degott, C. Funck-Brentano, 1985, Biochemical pharmacology.

Protective effect of 16,16-dimethyl prostaglandin E2 on the hepatotoxicity of bromobenzene in mice.

D. Pessayre, C. Degott, C. Funck-Brentano, 1984, Biochemical pharmacology.

Hepatotoxicity of trichloroethylene-carbon tetrachloride mixtures in rats. A possible consequence of the potentiation by trichloroethylene of carbon tetrachloride-induced lipid peroxidation and liver lesions.

D. Pessayre, M. Delaforge, C. Degott, 1982, Gastroenterology.

Cumulative effects of repeated doses of compounds transformed into reactive metabolites.

D. Pessayre, C. Degott, J. Benhamou, 1980, Biochemical pharmacology.

Effect of stavudine on mitochondrial genome and fatty acid oxidation in lean and obese mice.

D. Pessayre, B. Fromenty, C. Degott, 2001, The Journal of pharmacology and experimental therapeutics.

ROLE OF REPLICATIVE SENESCENCE IN THE PROGRESSION OF FIBROSIS IN HEPATITIS C VIRUS (HCV) RECURRENCE AFTER LIVER TRANSPLANTATION

V. Paradis, P. Marcellin, C. Degott, 2004, Transplantation.

Eotaxin expression and eosinophil infiltrate in the liver of patients with drug-induced liver disease.

C. Degott, A. Sauvanet, F. Durand, 2001, Journal of hepatology.

Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction.

D. Pessayre, C. Degott, J. Benhamou, 1977, Gastroenterology.

Mucin gene expression in intraductal papillary‐mucinous pancreatic tumours and related lesions

C. Degott, A. Sauvanet, P. Ruszniewski, 2002, The Journal of pathology.

Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant.

G. Labbe, D. Pessayre, B. Fromenty, 1990, Biochemical pharmacology.

Recurrence of Fabry's disease in a renal allograft eleven years after successful renal transplantation.

C. Degott, J. Mosnier, F. Degos, 1991, Transplantation.

Dihydralazine hepatitis: report of a case and review of the literature.

D. Pessayre, C. Degott, J. Bernuau, 1983, Digestion.

Metabolic activation of trichloroethylene into a chemically reactive metabolite toxic to the liver.

D. Pessayre, C. Degott, G. Feldmann, 1978, The Journal of pharmacology and experimental therapeutics.

Arthritis critically dependent on innate immune system players.

Ralph Weissleder, Umar Mahmood, Christophe Benoist, 2002, Immunity.

Analysis of the different histologic lesions observed in transbronchial biopsy for the diagnosis of acute rejection. Clinicopathologic correlations during the first 6 months after lung transplantation.

C. Degott, H. Mal, G. Leséche, 2005, Human pathology.

Chronic active hepatitis caused by benzarone.

D. Pessayre, C. Degott, J. Benhamou, 1987, Journal of hepatology.

Immunostaining for membrane attack complex of complement is related to cell necrosis in fulminant and acute hepatitis.

C. Degott, J. Scoazec, J. Belghiti, 1995, Gastroenterology.

Expression of complement-regulatory proteins in normal and UW-preserved human liver.

C. Degott, J. Scoazec, J. Belghiti, 1994, Gastroenterology.

Beclin 1 mRNA Strongly Correlates with Bcl-XLmRNA Expression in Human Hepatocellular Carcinoma

D. Pessayre, C. Degott, D. Bernuau, 2007, Cancer investigation.

Hepatocyte ultrastructural changes in alpha1-antitrypsin deficiency.

C. Degott, G. Feldmann, J. Bignon, 1974, Gastroenterology.

Virological and histological characteristics in anti-HCV positive subjects with normal transaminases levels

P. Marcellin, C. Degott, K. Cymes, 1995 .

Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients

D. Valla, C. Degott, N. Casadevall, 2002, Gut.

A new mouse model of rheumatoid arthritis: organ-specific disease provoked by systemic autoimmunity.

V. Kouskoff, C. Benoist, D. Mathis, 1997, Ryumachi. [Rheumatism].

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C

P. Marcellin, D. Valla, C. Degott, 1998, Hepatology.

A new hepadnavirus endemic in arctic ground squirrels in Alaska

M. Buendia, F. Tekaia, C. Degott, 1996, Journal of virology.

Peliosis hepatis in recipients of renal transplants.

C. Degott, J. Benhamou, H. Kreis, 1978, Gut.

Chronic hepatitis in kidney allograft recipients

F. Carnot, C. Degott, C. Bréchot, 1990, The Lancet.

Adenomatous hyperplasia of the liver in a patient with congenital hepatic fibrosis.

V. Vilgrain, C. Degott, J. Belghiti, 1994, Journal of hepatology.

Cholangiopathy and intrahepatic stones in sickle cell disease: coincidence or ischemic cholangiopathy?

D. Valla, C. Degott, J. Belghiti, 2000, American Journal of Gastroenterology.

The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases.

V. Vilgrain, C. Degott, J. Belghiti, 1994, Gastroenterology.

Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression

B. Balkau, C. Degott, E. Zafrani, 1999, Hepatology.

Relationship between composition of lymphoid cell infiltrates in the liver and replication status in chronic hepatitis B: an immunohistochemical study.

C. Degott, J. Mosnier, F. Degos, 1996, American journal of clinical pathology.

Focal nodular hyperplasia

C. Degott, C. Balabaud, P. Bioulac-Sage, 2002, Hepatology.

Prevalence of the haemochromatosis gene mutation in non-cirrhotic liver with hepatocellular carcinoma.

C. Degott, J. Belghiti, B. Terris, 1998, Journal of hepatology.

Hepatocellular carcinoma with normal adjacent liver. Hepatitis B virus DNA status.

P. Marcellin, C. Degott, H. Bismuth, 1989, Journal of hepatology.

Auxiliary liver transplantation: Regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure–a multicenter European study

Elie, J. Ringers, B. Portmann, 1996, Hepatology.

Metoprolol-induced hepatitis: rechallenge and drug oxidation phenotyping.

D. Pessayre, C. Degott, J. Benhamou, 1988, Annals of internal medicine.

Dengue virus induced hepatitis with chronic calcific changes

C. Degott, A. Fabre, F. Bruneel, 2001, Gut.

Studies of portal hemodynamics and hepatic oxygen consumption during acute liver allograft rejection.

R. Moreau, D. Valla, C. Degott, 1997, Transplantation.

Hepatitis C virus genotypes in French blood donors

P. Marcellin, C. Degott, J. Benhamou, 1995, Journal of medical virology.

Alcoholic-like liver lesions induced by nifedipine.

C. Degott, J. Benhamou, C. Vissuzaine, 1989, Journal of hepatology.

Peliosis hepatis, nodular regenerative hyperplasia of the liver, and light-chain deposition in a patient with Waldenström's macroglobulinemia.

C. Degott, J. Scoazec, G. Feldmann, 1988, Gastroenterology.

Myeloid metaplasia, perisinusoidal fibrosis, and nodular regenerative hyperplasia of the liver.

C. Degott, G. Feldmann, D. Bernuau, 2008, Liver.

Hepatocytic PAS-positive diastase-resistance inclusions in the absence of alpha-1-antitrypsin deficiency--high prevalence in alcoholic cirrhosis.

C. Degott, G. Feldmann, J. Benhamou, 1981, American journal of clinical pathology.

Mesalazine (5-aminosalicylic acid) induced chronic hepatitis

P. Marcellin, D. Pessayre, C. Degott, 1999, Gut.

Portal hypertension in systemic mastocytosis.

C. Degott, D. Lebrec, J. Capron, 1978, Gastroenterology.

Peliosis hepatis induced by 6-thioguanine administration.

D. Pessayre, D. Valla, C. Degott, 1988, Gut.

Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis

C. Benoist, C. Degott, E. Gravallese, 2019 .

Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis: A clinical and immune-logical study of a series of 150 patients with primary biliary cirrhosis

D. Dhumeaux, C. Degott, K. Lassoued, 1990 .

Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis.

C. Degott, K. Lassoued, F. Degos, 1990, Gastroenterology.

Ketoconazole-induced fulminant hepatitis.

H. Tilly, C. Degott, J. Bernuau, 1985, Gut.

The ciliated hepatic foregut cyst, an unusual bronchiolar foregut malformation: a histological, histochemical, and immunohistochemical study of 7 cases.

V. Vilgrain, C. Degott, J. Belghiti, 2000, Human pathology.

Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature.

D. Valla, C. Degott, J. Benhamou, 1987, The Quarterly journal of medicine.

Effect of fasting on metabolite-mediated hepatotoxicity in the rat.

D. Pessayre, C. Degott, J. Benhamou, 1979, Gastroenterology.

Spindle cell squamous carcinoma of the oesophagus: an analysis of 17 cases, with new immunohistochemical evidence for a clonal origin

C. Degott, A. Couvelard, B. Terris, 2001, Histopathology.

Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone.

C. Degott, P. Bedossa, J. Benhamou, 1996, Gastroenterology.

Impact and evolution of peliosis hepatis in renal transplant recipients.

F. Carnot, C. Degott, C. Legendre, 1994, Transplantation.

Multiple mixed adenoma‐focal nodular hyperplasia of the liver associated with spontaneous intrahepatic porto‐systemic shunt: a new type of vascular malformation associated with the multiple focal nodular hyperplasia syndrome?

V. Paradis, V. Vilgrain, D. Valla, 2006, Histopathology.

Non‐Hodgkin's lymphoma presenting as a primary tumor of the liver: Presentation, diagnosis and outcome in eight patients

N. Brousse, C. Degott, J. Scoazec, 1991, Hepatology.

Ultrastructural lesions of bile ducts in primary biliary cirrhosis. A comparison with the lesions observed in graft versus host disease.

C. Gisselbrecht, C. Degott, G. Feldmann, 1981, Human pathology.

Human pancreatic mucinous cystadenoma is characterized by distinct mucin, cytokeratin and CD10 expression compared with intraductal papillary‐mucinous adenoma

C. Degott, P. Bedossa, J. Belghiti, 2006, Histopathology.

Complement activation after ischemia-reperfusion in human liver allografts: incidence and pathophysiological relevance.

C. Degott, J. Scoazec, J. Belghiti, 1997, Gastroenterology.

Aspergillus intraabdominal abscess after liver transplantation successfully treated with itraconazole.

C. Degott, A. Sauvanet, J. Belghiti, 1992, Transplantation.

Iproclozide fulminant hepatitis. Possible role of enzyme induction.

D. Pessayre, C. Degott, J. Bernuau, 1978, Gastroenterology.

Recombinant human γ‐interferon in patients with chronic active hepatitis B: Pharmacokinetics, tolerance and biological effects

M. Loriot, P. Marcellin, C. Degott, 1990 .

Liver diseases and hepatic complications in renal transplant patients.

F. Carnot, C. Degott, S. Pol, 1988, Advances in nephrology from the Necker Hospital.

Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases

D. Valla, C. Degott, C. Gardin, 2001, American Journal of Gastroenterology.

Biliary obstruction resulting from Strongyloides stercoralis infection. Report of a case.

V. Vilgrain, C. Degott, A. Hadengue, 1994, Gut.

Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men

M. Loriot, P. Marcellin, D. Valla, 1999, Hepatology.

Hepatitis B core antigen in hepatocytes of patients with chronic active hepatitis

C. Degott, C. Bréchot, C. Trépo, 1980, Digestive Diseases and Sciences.

Hepatitis in renal transplant recipients.

C. Degott, F. Degos, 1989, Journal of hepatology.

Severe monochlorobenzene-induced liver cell necrosis.

C. Degott, A. Cailleux, J. Bernuau, 1991, Gastroenterology.

[Diffuse pulmonary aspergillosis occurring 4 years after removal of an aspergilloma].

C. Degott, F. Potet, P. Werner, 1973, Annales de medecine interne.

Recurrent cholestatic jaundice associated with generalized pustular psoriasis: evidence for a neutrophilic cholangitis.

R. Modigliani, C. Degott, M. Rybojad, 2000, Journal of Hepatology.

Assessment of the prevalence of genetic metabolic defects in acute fatty liver of pregnancy.

D. Pessayre, B. Fromenty, C. Degott, 1996, Journal of hepatology.

Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in microvesicular steatosis induced by this antibiotic

G. Labbe, D. Pessayre, C. Degott, 1988, Hepatology.

Apoptosis after ischemia-reperfusion in human liver allografts.

C. Degott, J. Scoazec, J. Belghiti, 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Prolonged cholestasis after troleandomycin-induced acute hepatitis.

G. Danan, D. Pessayre, C. Degott, 1987, Journal of hepatology.

Prolonged cholestasis after ajmaline-induced acute hepatitis.

D. Pessayre, C. Degott, G. Feldmann, 1986, Journal of hepatology.

Non-inflammatory herpes simplex hepatitis in an adult with chronic neutropenia.

C. Degott, J. Bernuau, J. Benhamou, 2008, Liver.

Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice.

D. Pessayre, B. Fromenty, C. Degott, 2002, Gastroenterology.

Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment.

C. Degott, Y. Chrétien, C. Bréchot, 2002, Journal of hepatology.

Characteristics of clometacin-induced hepatitis with special reference to the presence of anti-actin cable antibodies.

C. Degott, J. Paul, C. Johanet, 1989, Autoimmunity.

Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients.

F. Carnot, C. Degott, C. Bréchot, 1988, Gastroenterology.

Amitriptyline-induced prolonged cholestasis.

D. Pessayre, C. Degott, G. Feldmann, 1988, Gastroenterology.

Perhexiline maleate-induced cirrhosis.

M Bichara, D. Pessayre, C. Degott, 1979, Gastroenterology.

Chronic active hepatitis and giant multinucleated hepatocytes in adults treated with clometacin.

D. Pessayre, C. Degott, F. Degos, 1981, Digestion.

A possible relationship to treatment between hepatitis-associated antigen and chronic persistent hepatitis in Hodgkin's disease

C. Degott, S. Erlinger, N. Schlegel, 1973, Gut.

Relationship between liver histopathological changes and HBsAg in 111 patients treated by long-term hemodialysis.

C. Degott, P. Jungers, F. Degos, 2008, Liver.

Human chorionic gonadotrophin beta expression in malignant Barrett’s oesophagus

M. Vidaud, D. Vidaud, C. Degott, 2004, Virchows Archiv.

Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases

P. Pineau, D. Valla, C. Degott, 2000, Hepatology.

Non-fatal acute fatty liver of pregnancy.

C. Degott, J. Bernuau, J. Benhamou, 1983, Gut.

Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B.

P. Marcellin, D. Valla, C. Degott, 2002, Gastroenterology.

Recombinant Interferon-α for Chronic Hepatitis C in Patients Positive for Antibody to Human Immunodeficiency Virus

P. Marcellin, C. Degott, F. Degos, 1992 .

Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B

P. Marcellin, C. Degott, J. Nataf, 1990, Hepatology.

Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers.

P. Marcellin, C. Degott, B. Pham, 2002, Journal of hepatology.

Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg.

M. Loriot, P. Marcellin, C. Degott, 1997, Journal of hepatology.

Multivariate analysis of prognostic factors in fulminant hepatitis B

B. Yvonnet, C. Degott, J. Bernuau, 1986, Hepatology.

Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon- Therapy

P. Marcellin, C. Degott, A. Aupérin, 1997, Annals of Internal Medicine.

alpha-Interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimen.

P. Marcellin, C. Degott, J. Belghiti, 1995, Transplantation.

Prolonged interferon‐alpha therapy of hepatitis B virus‐related decompensated cirrhosis

P. Marcellin, D. Samuel, C. Degott, 1997, Journal of viral hepatitis.

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

F. Carrat, C. Degott, S. Pol, 2004, JAMA.

Long-term histologic and viral changes in patients with chronic hepatitis C who responded to alpha interferon.

P. Marcellin, C. Degott, N. Boyer, 2008, Liver.

Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferon

P. Marcellin, C. Degott, N. Boyer, 1991, The Lancet.

Identification and transmission of hepatitis B virus-related variants.

K. Isselbacher, J. Wands, C. Degott, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Activation of NF-kappaB, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas

Ping Liu, C. Degott, A. Sauvanet, 2002 .

Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.

G. Labbe, D. Pessayre, C. Degott, 1987, The Journal of pharmacology and experimental therapeutics.

Herpesvirus infection of the respiratory tract in patients with alcoholic hepatitis.

C. Rouzioux, C. Degott, F. Durand, 1992, Alcoholism, clinical and experimental research.

Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti‐HBe or HBsAg to Anti‐HBs seroconversion in patients with chronic hepatitis B

M. Loriot, P. Marcellin, C. Degott, 1992, Hepatology.

Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation

C. Degott, C. Bréchot, J. Bernuau, 1988, Digestive Diseases and Sciences.

Is renal transplantation involved in post-transplantation liver disease? A prospective study.

C. Degott, F. Degos, J. Benhamou, 1980, Transplantation.

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C

P. Marcellin, C. Degott, N. Boyer, 1995, Hepatology.

Cholangitis in the acquired immunodeficiency syndrome: report of two cases and review of the literature.

F. Brun-Vézinet, D. Valla, C. Degott, 1987, Gut.

Hepatitis C virus infection in anti-HIV positive and negative French homosexual men with chronic hepatitis: comparison of second- and third-generation anti-HCV testing.

P. Marcellin, C. Degott, B. Pham, 2008, Liver.

Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comité des Anti-Viraux.

P. Marcellin, C. Degott, F. Degos, 1992, The Journal of infectious diseases.

[Vidarabine treatment of chronic active hepatitis associated with hepatitis B virus multiplication. A randomized multicenter study].

P. Marcellin, M. Chevallier, P. Chossegros, 1987, Gastroenterologie clinique et biologique.

Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure.

G Goldfarb, B Rueff, C. Degott, 1982, Gastroenterology.

Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.

P. Marcellin, C. Degott, A. Aupérin, 1999, Journal of hepatology.

Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.

G. Labbe, D. Pessayre, B. Fromenty, 1990, The Journal of pharmacology and experimental therapeutics.

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long‐term retrospective cohort study

P. Marcellin, D. Valla, C. Degott, 2001, Hepatology.

Genetic Influences on the End-Stage Effector Phase of Arthritis

D. Gauguier, M. Lathrop, C. Benoist, 2001, The Journal of experimental medicine.

Quantitative RT‐PCR in cirrhotic nodules reveals gene expression changes associated with liver carcinogenesis

V. Paradis, I. Bièche, M. Vidaud, 2003, The Journal of pathology.

Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index.

Christophe Laurent, Pierre Bedossa, V. Paradis, 2003, The American journal of pathology.

Prevalence of Liver Disease and Contributing Factors in Patients Receiving Home Parenteral Nutrition for Permanent Intestinal Failure

C. Degott, B. Messing, P. Beau, 2000, Annals of Internal Medicine.

Organ-Specific Disease Provoked by Systemic Autoimmunity

V. Kouskoff, C. Benoist, D. Mathis, 1996, Cell.

From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins.

K. Rajewsky, C. Benoist, D. Mathis, 1999, Immunity.

Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression

A. Harris, C. Degott, K. Gatter, 2004, British Journal of Cancer.

Cholangiographic appearance simulating sclerosing cholangitis in metastatic adenocarcinoma of the liver.

V. Vilgrain, C. Degott, J. Belghiti, 1990, Gastroenterology.

Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease.

D. Pessayre, B. Fromenty, C. Degott, 1997, Gastroenterology.

Recurrent jaundice caused by recurrent hyperemesis gravidarum.

G. Danan, C. Degott, G. Feldmann, 1984, Gut.

Inflammatory pseudo-tumor of the liver : is pre-operative diagnosis possible ?

V. Vilgrain, C. Degott, J. Belghiti, 2005 .

Carbamazepine-induced acute cholangitis

D. Pessayre, C. Degott, A. Hadengue, 1987, Digestive Diseases and Sciences.

Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.

G. Labbe, D. Pessayre, B. Fromenty, 1990, The Journal of pharmacology and experimental therapeutics.

Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct.

D. Valla, C. Degott, A. Sauvanet, 2001, The New England journal of medicine.

Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression

C. Degott, J. Scoazec, F. Paraf, 2000, The Journal of pathology.

Chronic Q fever hepatitis complicated by extensive fibrosis.

C. Degott, J. Benhamou, D. Lebrec, 1988, Gastroenterology.

[Undifferentiated embryonal sarcoma of the liver in an adult: a case report].

C. Degott, A. Sauvanet, J. Belghiti, 2002, Annales de pathologie.

Subfulminant syncytial giant cell hepatitis: recurrence after liver transplantation treated with ribavirin.

P. Marcellin, C. Degott, A. Sauvanet, 1997, Journal of hepatology.

Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.

V. Paradis, D. Ouzan, C. Degott, 2007, Journal of hepatology.

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

F. Tubach, T. Asselah, P. Marcellin, 2003, Gut.

Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases

Pierre Bedossa, V. Paradis, J. Janeau, 2005, Hepatology.

Sinusoidal portal hypertension in hepatic amyloidosis.

C. Degott, J. Benhamou, D. Lebrec, 1991, Gut.

Fatal liver failure due to disulfiram.

C. Degott, J. Bernuau, J. Benhamou, 1989, Journal of clinical gastroenterology.

Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in a Caribbean patient.

C. Degott, A. Hadengue, J. Benhamou, 1990, Journal of clinical gastroenterology.

Congenital hepatic fibrosis: CT findings in 18 adults.

Giuseppe Brancatelli, V. Vilgrain, D. Valla, 2004, Radiology.

A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia.

V. Paradis, I. Bièche, M. Vidaud, 2003, Gastroenterology.

Epithelioid hemangioendothelioma, multiple focal nodular hyperplasias, and cavernous hemangiomas of the liver.

V. Vilgrain, C. Degott, J. Belghiti, 2009, Archives of pathology & laboratory medicine.

HLA-A1, B8-phenotype association and HBs antigenemia evolution in 440 hemodialyzed patients.

C. Degott, P. Jungers, J. Zingraff, 1977, Digestion.

Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion.

G. Fourel, M. Buendia, C. Degott, 1994, Oncogene.

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death

S Chevret, S. Chevret, C. Degott, 2000, Gut.

Differential expression of perforin and granzyme B in the liver of patients with chronic hepatitis C.

D. Valla, C. Degott, J. Mosnier, 2003, Human pathology.

Angiogenesis and extracellular matrix remodelling in bronchioloalveolar carcinomas: distinctive patterns in mucinous and non‐mucinous tumours

C. Degott, A. Couvelard, M. Fournier, 2004, Histopathology.

Close correlation between β-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas

P. Pineau, A. Dejean, D. Valla, 1999, Oncogene.

Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma.

V. Paradis, V. Vilgrain, I. Bièche, 2004, Gastroenterology.

Epithelioid hemangioendothelioma of the liver. Diagnostic features and role of liver transplantation.

C. Degott, J. Scoazec, H. Bismuth, 1988, Gastroenterology.

Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis

C. Degott, T. Poynard, D. Lebrec, 1987, Digestive Diseases and Sciences.

Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease.

D. Pessayre, B. Fromenty, D. Valla, 2001, Gastroenterology.

[Endolymphatic sac tumor: a rare tumor of internal ear. Report of two cases].

C. Degott, D. Bouccara, O. Sterkers, 2000, Annales de pathologie.

[Localized hypertrophic neuropathy: differential diagnosis of intraneural perineurioma].

F. Lisovoski, C. Degott, O. Sterkers, 2000, Annales de pathologie.

Hepatic lesions of vascular origin in multicentric Castleman's disease, plasma cell type: report of one case with peliosis hepatis and another with perisinusoidal fibrosis and nodular regenerative hyperplasia.

T. Molina, J. Diebold, C. Degott, 1995, Pathology, research and practice.

Liver in obesity.

C. Degott, A. Braillon, C. Quenum, 1985, Gut.

Transvenous (transjugular) liver biopsy

C. Degott, J. Benhamou, D. Lebrec, 1978, The American Journal of Digestive Diseases.

[Hepatic biopsy by transvenous approach in hemopathies with coagulation disorders].

N. Brousse, C. Degott, P. Solal-Céligny, 1983, Presse medicale.

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome

C. Degott, N. Ganne-Carrié, A. Hadengue, 1995, Digestive Diseases and Sciences.

Plasma cell variant of Castleman's disease localized to the liver: a case report.

C. Degott, J. Belghiti, J. Mosnier, 1996, European journal of gastroenterology & hepatology.

Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin

D. Pessayre, C. Degott, J. Benhamou, 1994, Digestive Diseases and Sciences.

Correlation between patterns of DNA mismatch repair hmlh1 and hmsh2 protein expression and progression of dysplasia in intraductal papillary mucinous neoplasms of the pancreas

C. Degott, A. Couvelard, J. Fléjou, 2004, Virchows Archiv.

Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses

C. Degott, P. Ruszniewski, B. Terris, 2000, Gut.

Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.

P. Marcellin, C. Degott, F. Degos, 1995, Gastroenterology.

Cigarette smoking and hepatic lesions in patients with chronic hepatitis C

D. Valla, C. Degott, F. Degos, 2001, Hepatology.

Obesity and diabetes as a risk factor for hepatocellular carcinoma

E. Abdalla, O. Farges, C. Degott, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome.

D. Pessayre, B. Fromenty, C. Degott, 1991, The Journal of pharmacology and experimental therapeutics.

Presence of Loa loa microfilariae in ascitic fluid.

C. Degott, J. Benhamou, M. Hautekeete, 1989, The Journal of infectious diseases.

Fulminant hepatitis after lisinopril administration.

D. Pessayre, C. Degott, J. Bernuau, 1990, Gastroenterology.

Portal hypertension and primary biliary cirrhosis.

C. Degott, D. Lebrec, J. Benhamou, 1976, Digestion.

Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest–Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study

Albert Tran, D. Ouzan, C. Degott, 2006, The American Journal of Gastroenterology.

Pirprofen-induced fulminant hepatitis.

G. Danan, D. Pessayre, C. Degott, 1985, Gastroenterology.

Multiple splenic nodules revealing Gaucher's disease

C. Degott, M. Bralet, J. Fléjou, 2002, Histopathology.

Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid

J. Belaiche, D. Pessayre, D. Samuel, 1995, Hepatology.

Serial transmission of a human non A-non B hepatitis viral strain to HBV-protected chimpanzees: successive histological and ultrastructural studies.

C. Degott, F. Degos, C. Trépo, 2008, Liver.

Clotiazepam-induced acute hepatitis.

D. Pessayre, C. Degott, J. Benhamou, 1989, Journal of hepatology.

Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3

C. Degott, Y. DeClerck, J. Vigneron, 2003, Cancer Gene Therapy.

Mucinous cystadenoma with mesenchymal over-growth: a new variant among pancreatic mucinous cystadenomas?

C. Degott, A. Sauvanet, A. Couvelard, 2004, Virchows Archiv.

Prospective study on anti‐hepatitis C virus–positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA

P. Marcellin, D. Valla, C. Degott, 2001, Hepatology.

Intraductal acinar cell carcinoma of the pancreas

C. Degott, A. Fabre, A. Sauvanet, 2008, Virchows Archiv.

Epithelioid hemangioendothelioma of the liver: an ultrastructural study.

C. Degott, J. Scoazec, G. Feldmann, 1989, Human pathology.

Effect of chronic administration of cyclosporin A on hepatic uptake and biliary secretion of bromosulfophthalein in rat

C. Degott, S. Erlinger, M. Dumont, 1991, Digestive Diseases and Sciences.

Hépatite fulminante mortelle imputable au nilutamide (Anandron).

C. Degott, F. Durand, P. Hammel, 1993 .

Ultrasonography in acute fatty liver of pregnancy.

C. Degott, B. Campillo, J. Bernuau, 1986, Annals of internal medicine.

Prolonged cholestasis after cyproheptadine-induced acute hepatitis.

D. Pessayre, C. Degott, J. Benhamou, 1987, Journal of clinical gastroenterology.

Metabolic activation of the tricyclic antidepressant amineptine--II. Protective role of glutathione against in vitro and in vivo covalent binding.

D. Pessayre, C. Degott, P. Lettéron, 1987, Biochemical pharmacology.

[Cirrhosis and biliary lithiasis in France: a postmortem study].

D. Samuel, C. Degott, J. Benhamou, 1988, Gastroenterologie clinique et biologique.

Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers.

D. Pessayre, B. Fromenty, C. Degott, 1993, Gut.

[An increase of choleresis in secondary biliary cirrhosis in rats is caused by bile duct secretion].

C. Degott, S. Erlinger, J. Taillandier, 1990, Gastroenterologie clinique et biologique.

[Alcoholic foamy steatosis: study of 3 cases].

C. Degott, J. Fléjou, B. Rueff, 1987, Gastroenterologie clinique et biologique.

Gold salt-induced cholestasis.

D. Pessayre, C. Degott, G. Feldmann, 1979, Digestion.

Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.

G. Labbe, D. Pessayre, C. Degott, 1988, The Journal of pharmacology and experimental therapeutics.

Effects of pregnancy on the toxicity and metabolism of acetaminophen in mice.

D. Pessayre, C. Degott, P. Lettéron, 1986, The Journal of pharmacology and experimental therapeutics.

[Allopurinol-induced hepatitis. Report of a case and review of the literature (author's transl)].

C. Degott, J. Benhamou, D. Lebrec, 1982, Gastroentérologie Clinique et Biologique.

Amodiaquine-induced fulminant hepatitis.

D. Pessayre, C. Degott, B. Campillo, 1988, Journal of hepatology.

Activation of NF-kappaB, AP-1 and STAT transcription factors is a frequent and early event in human hepatocarcinogenesis

C. Degott, A. Sauvanet, Ping Liu, 2002 .

Primary intrahepatic cholesterol stones

B. Gayet, C. Degott, G. Amouyal, 1992, Digestive Diseases and Sciences.

[Acinar cystic transformation of the pancreas (or acinar cell cystadenoma), a rare and recently described entity].

C. Degott, J. Belghiti, P. Ruszniewski, 2002, Annales de pathologie.

Metabolic activation of the antidepressant tianeptine. II. In vivo covalent binding and toxicological studies at sublethal doses.

G. Labbe, D. Pessayre, C. Degott, 1989, Biochemical Pharmacology.

Early expression of adhesion molecules after lung transplantation: evidence for a role of aggregated P-selectin-positive platelets in human primary graft failure.

Y. Castier, C. Degott, H. Mal, 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Prolonged cholestasis and ductopenia associated with tenoxicam.

T. Asselah, C. Degott, D. Cazals‐Hatem, 2003, Journal of hepatology.

Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method.

P. Marcellin, C. Degott, A. Aupérin, 1998, Journal of hepatology.

[Immunohistochemical and ultrastructural heterogeneity of gastrointestinal stromal tumors].

C. Degott, A. Sauvanet, J. Belghiti, 2001, Gastroentérologie Clinique et Biologique.

Recombinant human gamma-interferon in patients with chronic active hepatitis B: pharmacokinetics, tolerance and biological effects.

M. Loriot, P. Marcellin, C. Degott, 1990, Hepatology.

Intraductal acinar cell carcinoma of the pancreas

C. Degott, A. Fabre, A. Sauvanet, 2001, Virchows Archiv.

C ritical R oles for Interleukin 1 and Tum or N ecrosis Factor in A ntibody-induced A rthritis

C. Benoist, C. Degott, E. Gravallese, 2015 .